Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab

Serum LDH and neutrophil count were significant independent prognostic factors. This externally validated prognostic nomogram, could help clinicians to identify the patients who would benefit most from ipilimumab and consequently to improve resource allocation. These easily available biomarkers deserve further validation.